Xofigo (radium-223 dichloride)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Xofigo (radium-223 dichloride), covering 2024-10-10 to 2025-09-19. Get the full timeline:
Most recent: Clinical Trial Update: Phase III Radium 223 mCRPC-PEACE III [Phase 3]